Product Code: GVR-4-68039-995-0
Medical Biomimetics Market Growth & Trends:
The global medical biomimetics market size is expected to reach USD 52.2 billion by 2030, registering a CAGR of 6.7% over the forecast period, according to a new report by Grand View Research, Inc. Growing advancement in nanotechnology, increasing demand for prostheses and implant, rise in R&D activities associated with medical biomimetics and strategic activities by key market players are the major factors which are likely to drive the market growth. For instance, in April 2021, curasan AG expanded its distribution network in Europe, the company has added Silesia Dental and Implants Diffusion International SARL to its European distribution network.
Diseases affecting the cornea are most important cause of blindness across the globe. According to the WHO, around 2 million new cases of corneal blindness are reported every year. More than 30 million people across the globe are blind in one or both eyes from corneal disease and injury, while several suffer from degraded visual acuity. Numerous attempts to create reliable, robust, and scalable solutions for artificial cornea have been unsuccessful. As such, there exists an unmet need, the research and development activities are being carried out for affordable and long-lasting solutions for pathology, injury, and corneal blindness. For instance, in March 2022, researchers from the Centre for LV Prasad Eye Institute, IIT-Hyderabad and Cellular, and Molecular Biology developed an exclusive biomimetic corneal hydrogel, manufactured from discarded human corneas, which can be used for the treatment of corneal scarring, the main cause of corneal blindness.
Numerous companies in the medical biomimetics market are expanding their products in emerging markets. For instance, a most important new development, in November 2021, Osteopore has been granted a patent in China for its smart 3D biometric scaffolds. The technology was developed with scientists from NTU Singapore and was previously granted a European patent in early 2021. This patent is anticipated to create numerous research and development opportunities in the Chinese market and allows the company to tap into local expertise as part of its product advancement process.
The COVID-19 pandemic is anticipated to negatively impact the medical biomimetics market growth. The COVID-19 pandemic had a considerable effect on the number of patients looking for dental treatments. The overall reduction in the number of patients treated in the Hospitals in Jordan was about 90.4% (17,591 to 1689). As a result, the usage of these technologies was less during the COVID-19 pandemic.
Furthermore, with the escalating number of accidents, the implementation of biomimetics for orthopedics is projected to boom. According to Association for Safe International Road Travel, every year about 20 to 50 million people worldwide suffer from injuries that leads to permanent disability. Hence, such factors are estimated to impact positively the growth of the medical biomimetics market.
On the other hand, a stringent regulatory framework hinders the medical biomimetics industry's growth. Regarding the ever-increasing and widespread applications of biomimetic biomaterials in numerous medical fields, their precise assessment is of great significance. Although each biomaterial undergoes thorough premarket evaluation, the regulatory organizations receive a significant number of adverse event and complications reports each year. Moreover, biomaterials are integrated into biological systems, hence, they must fulfill all scientific requirements such as high biocompatibility, sufficiently long shelf-life, and accommodating biological interactions.
Medical Biomimetics Market Report Highlights:
- By type, the cardiovascular segment held the largest share of the medical biomimetics market. This is attributed to the increasing research activities and rising cases of cardiovascular diseases which in turn is likely to increase the adoption of biomimetics and anticipate the medical biomimetics market growth
- The wound healing segment is expected to grow exponentially over the forecast period. The demand for wound healing and wound care products is growing owing to the escalating number of surgical cases and the increasing prevalence of chronic diseases globally
- The drug delivery segment of the medical biomimetics market is anticipated to grow at the fastest rate due to crucial developments in nanotechnology that have facilitated efficient and accurate non-carrier drug delivery using biomimetics based devices. Adequate funding and advancements in research and development will boost the medical biomimetics market growth
- North America dominated the global medical biomimetics market in 2021 due to the high R&D investment, development of novel products, and strong funding from the government in the region
- The Asia Pacific is expected to grow significantly in the future owing to the expansion of business by key market players along with the increasing prevalence of chronic disorders
- A few of the key medical biomimetics market players include Otsuka Medical Devices Group, Stryker, Abbott, AVINENT Science and Technology, SynTouch Inc, Osteopore International Pte Ltd, and others
Table of Contents
Chapter 1 Research Methodology
- 1.1 Market Segmentation & Scope
- 1.1.1 Estimates And Forecast Timeline
- 1.2 Research Solutionology
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 Gvr's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information Or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis
- 1.6.1.1 Approach 1: Commodity flow approach
- 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
- 1.7 Global Market: CAGR Calculation
- 1.8 Research Assumptions
- 1.9 List of Secondary Sources
- 1.10 List of Primary Sources
- 1.11 Objectives
- 1.11.1 Objective 1
- 1.11.2 Objective 2
- 1.12 List Of Abbreviations
Chapter 2 Market Definitions
Chapter 3 Executive Summary
Chapter 4 Global Medical Biomimetics Market Variables, Trends, & Scope
- 4.1 Medical Biomimetics Market Lineage Outlook
- 4.1.1 Parent Market Outlook
- 4.2 Penetration and Growth Prospect Mapping
- 4.3 Market Driver Analysis
- 4.3.1 Growing Advancement In Nanotechnology
- 4.3.2 Increasing Demand For Prostheses And Implants
- 4.3.3 Rise In Research And Development Activities Associated With Medical Biomimetics
- 4.4 Market Restraint Analysis
- 4.4.1 Stringent Regulatory Framework
- 4.5 Key Opportunities
- 4.5.1 Growing Tissue Engineering Market
- 4.6 Medical Biomimetics Market - Pestle Analysis
- 4.7 Industry Analysis - Porter's
- 4.8 Major Deals And Strategic Alliances Analysis
- 4.8.1 Joint Ventures
- 4.8.2 Mergers And Acquisitions
- 4.8.3 Licensing And Partnership
- 4.8.4 Technology Collaborations
- 4.8.5 Strategic Divestments
- 4.9 COVID-19 Impact Analysis
Chapter 5 Medical Biomimetics Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)
- 5.1 Global Medical Biomimetics Market: Product Movement Analysis
- 5.2 Cardiovascular
- 5.2.1 Cardiovascular Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 5.3 Orthopedic
- 5.3.1 Orthopedic Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 5.4 Ophthalmology
- 5.4.1 Ophthalmology Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 5.5 Dental
- 5.5.1 Dental Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 5.6 Others
- 5.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6 Medical Biomimetics Market- Segment Analysis, By Application, 2018 - 2030 (Usd Million)
- 6.1 Medical Biomimetics Market: Application Movement Analysis
- 6.2 Wound Healing
- 6.2.1 Wound Healing Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.3 Tissue Engineering
- 6.3.1 Tissue Engineering Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.4 Drug Delivery
- 6.4.1 Drug Delivery Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.5 Other Applications
- 6.5.1 Other Applications Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 7 Medical Biomimetics Market: - Segment Analysis, by Region, 2018 - 2030 (USD Million)
- 7.1 Medical Biomimetics Market: Regional Movement Analysis
- 7.2 North America
- 7.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.2.2 U.S.
- 7.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.2.3 Canada
- 7.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.3 Europe
- 7.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.3.2 U.K.
- 7.3.2.1 Uk Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.3.3. Germany
- 7.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.3.4 France
- 7.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.3.5. Italy
- 7.3.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.6 Spain
- 7.3.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.4 Asia Pacific
- 7.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.4.2 Japan
- 7.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.4.3 China
- 7.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.4.4 India
- 7.4.4.1 India Market Estimates And Forecast, 2018-2030
- 7.4.5 South Korea
- 7.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.4.6 Australia
- 7.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.5 Latin America
- 7.5.1 Latin America Market Estimates AND FORECAST, 2018 - 2030 (USD Million)
- 7.5.2 Brazil
- 7.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.5.3 Mexico
- 7.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.5.4 Argentina
- 7.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.6 Middle East & Africa (Mea)
- 7.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.6.2 South Africa
- 7.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.6.3 Saudi Arabia
- 7.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.6.4 Uae
- 7.6.4.1 Uae Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 8 Competitive Landscape
- 8.1 Public Companies
- 8.1.1 Company Market Position Analysis
- 8.1.2 Competitive Dashboard Analysis
- 8.1.3 Strategic Framework
- 8.2 Private Companies
- 8.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
- 8.2.2 Regional Network Map
- 8.3 Company Profiles
- 8.3.1 OTSUKA MEDICAL DEVICES GROUP
- 8.3.1.1 Company Overview
- 8.3.1.2 Financial Performance
- 8.3.1.3 Product Benchmarking
- 8.3.1.4 Strategic Initiatives
- 8.3.2 STRYKER
- 8.3.2.1 Company Overview
- 8.3.2.2 Financial Performance
- 8.3.2.3 Product Benchmarking
- 8.3.2.4 Strategic Initiatives
- 8.3.3 ABBOTT
- 8.3.3.1 Company Overview
- 8.3.3.2 Financial Performance
- 8.3.3.3 Product Benchmarking
- 8.3.3.4 Strategic Initiatives
- 8.3.4 AVINENT SCIENCE AND TECHNOLOGY
- 8.3.4.1 Company Overview
- 8.3.4.2 Financial Performance
- 8.3.4.3 Product Benchmarking
- 8.3.4.4 Strategic Initiatives
- 8.3.5 SYNTOUCH INC
- 8.3.5.1 Company Overview
- 8.3.5.2 Financial Performance
- 8.3.5.3 Product Benchmarking
- 8.3.5.4 Strategic Initiatives
- 8.3.6 OSTEOPORE INTERNATIONAL PTE LTD
- 8.3.6.1 Company Overview
- 8.3.6.2 Financial Performance
- 8.3.6.3 Product Benchmarking
- 8.3.6.4 Strategic Initiatives
- 8.3.7 VANDSTROM, INC.
- 8.3.7.1 Company Overview
- 8.3.7.2 Financial Performance
- 8.3.7.3 Product Benchmarking
- 8.3.7.4 Strategic Initiatives
- 8.3.8 BIOMIMETICS TECHNOLOGIES INC
- 8.3.8.1 Company Overview
- 8.3.8.2 Financial Performance
- 8.3.8.3 Product Benchmarking
- 8.3.8.4 Strategic Initiatives
- 8.3.9 SWEDISH BIOMIMETICS 3000 APS
- 8.3.9.1 Company Overview
- 8.3.9.2 Financial Performance
- 8.3.9.3 Product Benchmarking
- 8.3.9.4 Strategic Initiatives
- 8.3.10 LIFEMATRIX
- 8.3.10.1 Company Overview
- 8.3.10.2 Financial Performance
- 8.3.10.3 Product Benchmarking
- 8.3.10.4 Strategic Initiatives
- 8.3.11 KEYSTONE DENTAL GROUP
- 8.3.11.1 Company Overview
- 8.3.11.2 Financial Performance
- 8.3.11.3 Product Benchmarking
- 8.3.11.4 Strategic Initiatives
- 8.3.12 CURASAN, INC.
- 8.3.12.1 Company Overview
- 8.3.12.2 Financial Performance
- 8.3.12.3 Product Benchmarking
- 8.3.12.4 Strategic Initiatives
- 8.3.13 CORNEAT VISION
- 8.3.13.1 Company Overview
- 8.3.13.2 Financial Performance
- 8.3.13.3 Product Benchmarking
- 8.3.13.4 Strategic Initiatives
- 8.3.14 NANOHIVE MEDICAL LLC
- 8.3.14.1 Company Overview
- 8.3.14.2 Financial Performance
- 8.3.14.3 Product Benchmarking
- 8.3.14.4 Strategic Initiatives
- 8.3.15 ZIMMER BIOMET
- 8.3.15.1 Company Overview
- 8.3.15.2 Financial Performance
- 8.3.15.3 Product Benchmarking
- 8.3.15.4 Strategic Initiatives